---
title: Veterans Nature Therapy (Vet Hike)
nct_id: NCT03997344
overall_status: COMPLETED
phase: NA
sponsor: University of Washington
study_type: INTERVENTIONAL
primary_condition: Posttraumatic Stress Disorders
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT03997344.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT03997344"
ct_last_update_post_date: 2021-06-14
last_seen_at: "2026-05-12T06:35:09.085Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Veterans Nature Therapy (Vet Hike)

**Official Title:** Veterans Nature Therapy: A Pilot Randomized Trial of Hiking for Veterans With PTSD

**NCT ID:** [NCT03997344](https://clinicaltrials.gov/study/NCT03997344)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 26
- **Lead Sponsor:** University of Washington
- **Collaborators:** VA Puget Sound Health Care System, Recreational Equipment, Inc. (REI)
- **Conditions:** Posttraumatic Stress Disorders
- **Start Date:** 2019-05-10
- **Completion Date:** 2020-03-01
- **CT.gov Last Update:** 2021-06-14

## Brief Summary

This pilot study evaluates the feasibility of conducting a study to evaluate the impact of nature exposure/hiking in groups on symptoms of posttraumatic stress disorder in Veterans. Participants will be randomized to one of two groups: 1) nature hikes and 2) urban hikes.

## Detailed Description

Objectives and hypothesis: Posttraumatic stress disorder (PTSD) is a tragically common problem among US Military Veterans. Current treatment options for PTSD are not uniformly effective and dropout rates are high. Treatment approaches that are evidence-based, effective, and acceptable to Veterans are needed. Nature therapy is a promising, low-cost intervention, yet there are few rigorous studies that have evaluated it as a therapeutic intervention in Veterans with PTSD.

The specific aims of this study are to lay the ground work for a full-scale study by assessing the feasibility and acceptability of: i) recruitment, screening, and data collection methods; and ii) the nature hiking and urban hiking control group interventions. The investigators hypothesize that the interventions will be feasible and the recruitment, screening, and data collection methods will be acceptable.

Key eligibility criteria for this two-arm pilot randomized controlled trial include being a Veterans with PTSD, physical fitness/ability sufficient to walk for at least 2 hours, and willingness to complete assessments. Eligible individuals will be randomized to one of two groups: 1) nature hiking group, 2) urban hiking group. The investigators will enroll up to 60 individuals, to randomize up to 15 participants per group. Note that the number enrolled and randomized are not expected to be the same since he investigators anticipate some individuals who enroll will be determined not to be eligible based on responses to the baseline questionnaire. Individuals randomized to groups 1 or 2 will be invited to participate in six hikes of 2-4 hours in duration, over approximately 12 weeks. Individuals will be asked to complete questionnaires at baseline and weekly for 12 weeks, and then again at 24 weeks. The primary outcomes for this study relate to feasibility and acceptability. The investigators will collect information on time to recruit the sample, retention and survey completion at each time point, and attendance at hikes. A secondary aim is to ascertain changes in PTSD symptoms (which will serve as the primary outcome of the full-scale trial), secondary outcomes (e.g., quality of life) and mediators of the intervention, including factors such as depression, perceived stress, affect, loneliness, anxiety, social connectedness, rumination, and nature connection.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* U.S. Military Veteran;
* Active PTSD symptoms based on the PCL-5;
* No diagnosis of schizophrenia, bipolar disorder, or other psychotic disorders (based on self-report);
* Low risk of suicide (based on responses to the MINI Suicidal module);
* No inpatient admission in last 3 months (based on self-report);
* No current alcohol disorder/dependence (based on having a score\<16 on the 10-item self-administered AUDIT questionnaire);
* No evidence of drug-related problems (based on having a score \<3 on the DAST-10)
* Capable of safely participating in hikes as evidenced by no "yes's" on the Physical Activity Readiness Questionnaire (or approval of their primary care physician) and individual assertion that they can walk at least 2 hours at an easy to moderate effort with breaks;
* Willing to be randomized to one of two groups and complete all study procedures;
* Able to provide written informed consent to participate.

Exclusion Criteria:

* Schizophrenia, bipolar disorder or other psychotic disorder
```

## Arms

- **Nature hiking** (EXPERIMENTAL) — Group hikes in a natural setting (e.g., park, wilderness area)
- **Urban hikes** (ACTIVE_COMPARATOR) — Group hikes in a urban setting (e.g., downtown area)

## Interventions

- **Group nature hikes** (BEHAVIORAL) — Six group nature hikes will be offered once every other week. Total duration of intervention is 12 weeks. Hikes will be co-lead by two experienced hike leaders.
- **Group urban hikes** (BEHAVIORAL) — Six group urban hikes will be offered once every other week. Total duration of intervention is 12 weeks. Hikes will be co-lead by two experienced hike leaders.

## Primary Outcomes

- **Recruitment** _(time frame: Baseline)_ — Time to recruit the sample
- **Recruitment** _(time frame: Baseline)_ — Percentage of individuals contacted who are randomized
- **Retention** _(time frame: 12-week follow-up)_ — Percentage of participants that complete assessments

## Secondary Outcomes

- **PTSD symptoms** _(time frame: Baseline and 6-, 12-, 24-week follow-ups)_
- **Quality of life/well-being: Satisfaction with Life Scale** _(time frame: Baseline and 6-, 12-, 24-week follow-ups)_
- **Depression** _(time frame: Baseline and 6-, 12-, 24-week follow-ups)_
- **Perceived stress** _(time frame: Baseline and 6-, 12-, 24-week follow-ups)_
- **Social connectedness** _(time frame: Baseline and 6-, 12-, 24-week follow-ups)_
- **Rumination** _(time frame: Baseline and 6-, 12-, 24-week follow-ups)_

## Locations (1)

- VA Puget Sound Health Care System, Seattle, Washington, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.va puget sound health care system|seattle|washington|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT03997344.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT03997344*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*